CSI Market
Sign In | Register

Immunitybio inc (IBRX) Annual Balance Sheets

Annual · GAAP · USD millions
Access IBRX quarterly Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Immunitybio inc manages assets, liabilities, and equity through different cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent88.33
Marketable Securities, Current SH154.48
Cash & Short-term Investments242.00
Accounts receivable42.57
Other Receivables, Net, Current0.05
Inventories0.91
Prepaid Expense And Other Assets Current28.53
Total Current Assets314.88
Equipment/Property/Plant Net114.26
Intangible Assets13.95
Long-term investments0.00
Other Assets, Noncurrent58.81
Operating Lease Right Of Use Asset33.01
Total Assets501.90
Liabilities
Accounts Payable, Current AC0.40
Other Liabilities, Current61.35
Total Current Liabilities61.75
Long-term debt324.62
Secured Debt324.62
Convertible Notes Payable, Noncurrent LO477.09
Total Long-term Debt801.71
Other liabilities, Noncurrent138.01
OperatingLeaseLiabilityNoncurrent33.45
Operating Lease Liability Current7.54
Convertible Notes Payable Noncurrent Fair Value Option-
Total Liabilities1,001.47
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock3,197.12
Retained Earnings / Accumulated Deficit-3,726.65
Defined Benefit Plan and Other84.42
Other Equity-55.36
Common Stockholder's Equity-500.47
Non-controlling interests & other0.90
Total Stockholder's Equity-499.57
Liabilities & Stockholder's Equity501.90
4 historic quarters locked

Sign in to unlock the full Immunitybio inc balance sheet history.

Sign In Create Free Account

About Immunitybio Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 23, 2026
  • Source: ibrx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001326110-26-000030

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License